Achilles therapeutics announces grant of us patent covering the treatment of patients with an immunotherapy targeting neoantigens based on tumor hla status

- patent broadly covers technology to select neoantigens that are presented by hla molecules determined to be present in a patient's tumor -

ACHL Ratings Summary

ACHL Quant Ranking